The role of leukodepletion in limiting ischemia/reperfusion damage in the heart, lung and lower extremity

Allen, BS
May 2002
Perfusion;May2002 Supplement 1, Vol. 17, p11
Academic Journal
This article describes the experimental infrastructure and subsequent clinical application of a comprehensive reperfusion strategy to limit the injury following ischemia, resulting in an improvement in post operative organ function. In particular, it examines the role of luekodepletion in minimizing damage and improving functional outcome in the heart, lung and lower extremity. During cardiothoracic procedures, various organs can be subjected to temporary ischemia, particularly the heart (cardioplegic arrest), lung (transplant), and lower extremity (femoral canulation, IABP).The background of ischemia/reperfusion injury is discussed as it applies to each of these 3 organs, as well as findings that ischemia followed by reperfusion results in a similar injury in each organ. Data are then presented to demonstrate that a comprehensive reperfusion strategy, utilizing a modified substrate-enriched blood reperfusate delivered at a low pressure can limit this injury, and that adding white blood cell filtration significantly improves the efficacy of this approach. These principles have now been used in a series of patients undergoing various surgical procedures with excellent results. Application of these concepts may significantly improve the outcome in patients undergoing procedures which subject these organs to temporary ischemia.


Related Articles

  • Surfactant pretreatment ameliorates ischemia-reperfusion injury of the lung. van der Kaaij, Niels P.; Haitsma, Jack J.; Kluin, Jolanda; Lambrecht, Bart N.; Lachmann, Burkhard; de Bruin, Ron W.F.; Bogers, Ad J.J.C. // European Journal of Cardio-Thoracic Surgery;May2005, Vol. 27 Issue 5, p774 

    Abstract: Objective: To investigate whether surfactant pretreatment provides lung protection in an animal model of lung ischemia-reperfusion injury (LIRI). Methods: Male Sprague–Dawley rats (n=100) were randomised to receive intratracheally administered surfactant or no pretreatment. One...

  • Retroinfusion of NF[subkappa]B decoy oligonucleotide extends cardioprotection achieved by CD18 inhibition in a preclinical study of myocardial ischemia and retroinfusion in pigs. Kupatt, C.; Wichels, R.; DeiB, M.; Molnar, A.; Lebherz, C.; Raake, P.; von Degenfeld, G.; Hahnel, D.; Boekstegers, P. // Gene Therapy;4/15/2002, Vol. 9 Issue 8, p518 

    Reports that retroinfusion of NFkB decoy oligonucleotide extends cardioprotection achieved by CD18 inhibition in a preclinical study of myocardial ischemia and retroinfusion in pigs. Myocardial reperfusion injury; Oligonucleotide transfection; Liposomes.

  • Leucocyte filtration during cardiopulmonary reperfusion in coronary artery bypass surgery. Baksaas, S.T.; Flom-Halvorsen, H.I.; Øvrum, E.; Videm, V.; Mollnes, T.E.; Brosstad, F.; Svennevig, J.L. // Perfusion;1999, Vol. 14 Issue 2, p107 

    Postoperative organ dysfunction after cardiac operations has been related to the damaging effects of cardiopulmonary bypass (CPB). These complications are considered to be mediated partly by complement activation and subsequent activation of leucocytes due to the contact between blood and the...

  • Role of platelets in coronary thrombosis and reperfusion of ischemic myocardium Gawaz, Meinrad // Cardiovascular Research;Feb2004, Vol. 61 Issue 3, p498 

    Platelet-dependent thrombus formation is a key event in the pathogenesis of acute myocardial infarction (AMI). Platelets mediate both thrombotic occlusion of the entire epicardial coronary artery and also accumulate in the microcirculation resulting in impairment of microcirculation and...

  • Low dose cyclophosphamide rescues myocardial function from ischemia-reperfusion in rats Zhu, Jianhua; Qiu, Yuangang; Wang, Qiqi; Zhu, Yujuan; Hu, Shenjiang; Zheng, Liangrong; Wang, Lihong; Zhang, Yun // European Journal of Cardio-Thoracic Surgery;Sep2008, Vol. 34 Issue 3, p661 

    Abstract: Objectives: The effect of low dose of cyclophosphamide (CP) protecting cardiac function from ischemia-reperfusion injury was studied on rats. The premise is that CP inhibits immune and inflammatory process, thereby limits I/R injury and improves myocardial function. Methods: Open chest...

  • Pharmacokinetics of rhuMAb CD18, a Recombinant Humanised Monoclonal Antibody Fragment to CD18, in Normal Healthy Human Volunteers. Allison, D.E.; Gourlay, S.G.; Koren, E.; Miller, R.M.; Fox, J.A. // BioDrugs;2002, Vol. 16 Issue 1, p63 

    Background and Objectives: Leucocyte β2 integrin adhesion receptors are hypothesised as a therapeutic target to modify immune responses to ischaemia-reperfusion injury that may be detrimental to recovery in a variety of disease states. Two phase I studies were designed to evaluate the...

  • Chemokine expression in renal ischemia/reperfusion injury is most profound during the reparative phase. Stroo, Ingrid; Stokman, Geurt; Teske, Gwen J. D.; Raven, Anje; Butter, Loes M.; Florquin, Sandrine; Leemans, Jaklien C. // International Immunology;Jun2010, Vol. 22 Issue 6, p433 

    Chemokines are important players in the migration of leukocytes to sites of injury and are also involved in angiogenesis, development and wound healing. In this study, we performed microarray analyses to identify chemokines that play a role during the inflammatory and repair phase after renal...

  • Addition of a neutrophil elastase inhibitor to the organ flushing solution decreases lung reperfusion injury in rat lung transplantation Mori, Hideaki; Nagahiro, Itaru; Osaragi, Tomohiko; Kotani, Kazutoshi; Nakanishi, Hidehiro; Sano, Yoshifumi; Date, Hiroshi; Shimizu, Nobuyoshi // European Journal of Cardio-Thoracic Surgery;Nov2007, Vol. 32 Issue 5, p791 

    Abstract: Background: Neutrophil elastase plays an important role in ischemia–reperfusion injury. We hypothesized that the addition of sivelestat, a specific neutrophil elastase inhibitor, to the organ flushing solution would decrease reperfusion injury in a rat single left-lung...

  • Effects of neutrophil elastase inhibitor on flap survival after venous ischemia. Kotsu, Kunio; Hashimoto, Ichiro; Yamano, Masahiro; Kashiwagi, Keisuke; Abe, Yoshiro; Nakanishi, Hideki // European Journal of Plastic Surgery;Mar2013, Vol. 36 Issue 3, p149 

    Background: Venous ischemia is more of a threat to tissue viability than is arterial ischemia. The mechanism of injury is complex and involves many factors. Neutrophil activation is thought to be a trigger and final pathway for the tissue injury. Methods: We conducted a two-part animal study to...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics